NEW YORK (GenomeWeb News) – Illumina President Francis deSouza has taken a seat on the firm's board of directors. The company said this week that it added a spot on the board, boosting its number from nine to 10 seats, to accommodate deSouza. He will stand for re-election at the firm's 2014 shareholder meeting.
DeSouza joined Illumina as president in December. He previously was president of products and services at Symantec, which was acquired by Imlogic, a firm that deSouza founded and for which he served as CEO. He also worked at Microsoft, where he developed the company's real-time collaboration offerings.
Becton Dickinson has appointed Amit Bhalla to be VP of global strategy and development. In the role, Bhalla will work with the senior management team to develop BD's overall strategy.
Bhalla joins BD from Citi, where he has been director of equity research for life science tools and medical technology since 2006. Before joining Citi, he was VP of equity research for emerging medical technology at Morgan Stanley, and a technical operations R&D associate at Johnson and Johnson.
Ardy Arianpour has joined Pathway Genomics as chief strategy officer, the company said this week.
Arianpour most recently was senior VP of business development at Ambry Genetics, and during his 13-year career in the biotech sector he also has worked in senior sales and business development roles at Clinical Data, Cogenics, and Eurogentec North America. In his new post, Arianpour will lead the San Diego-based company's global strategy, strategic planning, and partnership activities.
Baylor College of Medicine's Jim Lupski has received the 2014 Environmental Mutagenesis and Genomics Society Award in recognition of his work in characterizing human mutations and linking them to disease. Lupski, a professor of molecular and human genetics at BCM, has relied on chromosomal microarrays and whole-genome sequencing to discover several disease genes, including the first gene for Charcot-Marie Tooth syndrome.
EMGS recognizes one researcher each year for outstanding research contributions in the area of environmental mutagenesis and genomics. Lupski will receive the award on Sept. 16 at the society's annual meeting in Orlando, Fla.
Atossa Genetics said this week that John Barnhart plans to retire from the firm's board of directors to pursue other personal and professional activities. The company said it plans to appoint a new board member to replace Barnhart.
GenomOncology said this week it has named John Doulis to serve on its board of directors, in connection with an investment from TriStar Technology Ventures.
Doulis is chief information officer for MedCare Investment Funds, which is a partner fund to TriStar. He has two decades of experience as a physician, executive, scientist, and healthcare information systems designer and manager, including serving as assistant vice chancellor and chief operations officer for the Informatics Center at Vanderbilt University.
The UK life sciences management consulting firm Alacrita has named Mark Wickham as a partner. Based in London, Wickham will focus on growing the company's medical technologies business. He formerly held senior operations roles at Smith and Nephew, London International Group, Bespak, Bio-del, and B1 Medical.
Agilent Technologies has tapped Guillermo Gualino to be its VP and treasurer.
Gualino, who has been serving as assistant treasurer, replaces Robert Cantrell, who will shift to Keysight Technologies, a new electronic measurement company to be formed by Agilent's split into two publicly traded companies. Gualino will report to Agilent CFO Didier Hirsch.
Before he joined Agilent, Gualino was assistant treasurer at Flextronics International and he worked in finance at Ernst and Young, PricewaterhouseCoopers, and the Ventana Growth Fund.
Promoted? Changing jobs? GenomeWeb wants to know. [email protected] to appear in People In The News, a weekly roundup of industry comings and goings.